Central pontine myelinolysis. A clinical and pathological study of 10 cases.
D000328:Adult; D000437:Alcoholism / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D001806:Blood Urea Nitrogen; D001927:Brain Diseases / Q000150:complications / Q000473:pathology*; D002675:Child, Preschool; D003711:Demyelinating Diseases / Q000473:pathology*; D004569:Electroencephalography; D005260:Female; D006527:Hepatolenticular Degeneration / Q000150:complications; D006801:Humans; D007022:Hypotension / Q000209:etiology; D008107:Liver Diseases / Q000150:complications; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology; D009186:Myelin Sheath; D009748:Nutrition Disorders / Q000150:complications; D011149:Pons / Q000473:pathology*; D013129:Spinal Puncture; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014899:Wernicke Encephalopathy / Q000473:pathology
D000900:Anti-Bacterial Agents; D014662:Vasoconstrictor Agents